Alpha Lipoic Acid is named as an intervention in 3 current clinical trials in our China and India registers. 1 is recruiting patients now. The most common phase is Phase 2/3. The sponsor with the most trials is St. John's Research Institute (1). The most-studied condition is Diabetic Neuropathy Peripheral.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.
NCT06201611 · ClinicalTrials.gov ↗ · Diabetic Neuropathy Peripheral
|
Phase 2/3 | Recruiting | St. John's Research Institute | India |
|
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
NCT07725484 · ClinicalTrials.gov ↗ · Heart Failure Due to Coronary Artery Disease
|
Phase 3 | Not yet open | Shanghai Zhongshan Hospital | China |
|
Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
NCT07381361 · ClinicalTrials.gov ↗ · Burning Mouth Syndrome, Low Level Laser Therapy
|
Not applicable | Active, closed | Lu Jiang | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| St. John's Research Institute | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Lu Jiang | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 0 |
| Clinical trials in India | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our China and India registers name Alpha Lipoic Acid as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 3 trials is recruiting: 1 with sites in India. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
St. John's Research Institute (1), Shanghai Zhongshan Hospital (1) and Lu Jiang (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Alpha Lipoic Acid works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Alpha Lipoic Acid works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Alpha Lipoic Acid (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.